Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats

Psychopharmacology

Volumn 225, Issue 1, 2013, Pages 75-93

  Páleníček, Tomáš ^a   Fujáková, Michaela ^a,b   Brunovský, Martin ^a   Horáček, Jiří ^a   Gorman, Ingmar ^a   Balíková, Marie ^b   Rambousek, Lukáš ^c,d   Syslová, Kamila ^c   Kačer, Petr ^c   Zach, Petr ^b   Bubeníková Valešová, Věra ^a   Tylš, Filip ^a,b   Kubešová, Anna ^a,b   Puskarčíková, Jana ^a,b   Höschl, Cyril ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

4 Bromo 2,5 dimethoxyphenethylamine (2C B); Amphetamine; Behavior; Dopamine; EEG coherence; EEG power spectra; Microdialysis; Nucleus accumbens; Rats; Serotonin

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; BROLAMFETAMINE; DOPAMINE;

ALPHA RHYTHM; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; LOCOMOTION; MALE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD BEHAVIOR; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; STARTLE REFLEX; THETA RHYTHM;

3,4-DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; DIMETHOXYPHENYLETHYLAMINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HALLUCINOGENS; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 84872362811     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2797-7     Document Type: Article

References (97)

1. Acuna-Castillo C, Villalobos C, Moya PR, Saez P, Cassels BK, Huidobro-Toro JP (2002) Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors. Br J Pharmacol 136:510-519
2. Adams LM, Geyer MA (1982) LSD-induced alterations of locomotor patterns and exploration in rats. Psychopharmacol (Berl) 77:179-185
3. Ambrosini MV, Gambelunghe C, Mariucci G, Bruschelli G, Adami M, Giuditta A (1994) Sleep-wake variables and EEG power spectra in Mongolian gerbils and Wistar rats. Physiol Behav 56:963-968
4. Berankova K, Szkutova M, Balikova M (2007) Distribution profile of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous doses. Forensic Sci Int 170:94-99
5. Bossong MG, Van Dijk JP, Niesink RJ (2005) Methylone and mCPP, two new drugs of abuse? Addict Biol 10:321-323
6. Bourin M, Petit-Demouliere B, Dhonnchadha BN, Hascoet M (2007) Animal models of anxiety in mice. Fundam Clin Pharmacol 21:567-574
7. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L, Malhotra AK, Pickar D (1998) Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29:142-147
8. Bronson ME, Jiang W, DeRuiter J, Clark CR (1995) A behavioral comparison of Nexus, cathinone, BDB, and MDA. Pharmacol Biochem Behav 51:473-475
9. Brunell SC, Spear LP (2006) Effects of acute ethanol or amphetamine administration on the acoustic startle response and prepulse inhibition in adolescent and adult rats. Psychopharmacology 186:579-586
10. Bubenikova V, Votava M, Horacek J, Palenicek T (2005) Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA). Behav Pharmacol 16:127-130
11. Carmo H, de Boer D, Remiao F, Carvalho F, dos Reys LA, de Lourdes BM (2004) Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration. JChromatogrB Analyt Technol Biomed Life Sci 811:143-152
12. Carmo H, Hengstler JG, de Boer D, Ringel M, Remiao F, Carvalho F, Fernandes E, dos Reys LA, Oesch F, de Lourdes BM (2005) Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human. Toxicology 206:75-89
13. Caudevilla-Galligo F, Riba J, Ventura M, Gonzalez D, Farre M, Barbanoj MJ, Bouso JC (2012) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. J Psychopharmacol 26:1026-1035
14. Cole MD, Lea C, Oxley N (2002) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature. Sci Justice 42:223-224
15. Davis M (1987) Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists. Psychopharmacol (Berl) 93:286-291
16. Davis M, Walters JK (1977) Psilocybin: biphasic dose-response effects on the acoustic startle reflex in the rat. Pharmacol Biochem Behav 6:427-431
17. de Boer D, Bosman I (2004) A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs. Pharm World Sci 26:110-113
18. de Boer D, Gijzels MJ, Bosman IJ, Maes RA (1999) More data about the new psychoactive drug 2C-B. J Anal Toxicol 23:227-228
19. de Boer D, Bosman IJ, Hidvegi E, Manzoni C, Benko AA, dos Reys LJ, Maes RA (2001) Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 121:47-56
20. Deutch AY, Cameron DS (1992) Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46:49-56
21. Dimpfel W, Spuler M, Borbe HO (1988) Monitoring of the effects of antidepressant drugs in the freely moving rat by radioelectroencephalography (tele-stereo-EEG). Neuropsychobiology 19:116-120
22. Dimpfel W, Spuler M, Nichols DE (1989) Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG). Psychopharmacol (Berl) 98:297-303
23. EMCDDA (2004) Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs. European monitoring Centre for Drugs and Drug Addiction (EMCDDA)
24. Everson CA, Bergmann BM, Rechtschaffen A (1989a) Sleep deprivation in the rat: III. Total sleep deprivation. Sleep 12:13-21
25. Everson CA, Gilliland MA, Kushida CA, Pilcher JJ, Fang VS, Refetoff S, Bergmann BM, Rechtschaffen A (1989b) Sleep deprivation in the rat: IX. Recover Sleep 12:60-67
26. Fiserova M, Consolo S, Krsiak M (1999) Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacol (Berl) 142:85-94
27. Fujakova M, Palenicek T, Tyls F, Kubesova A, Brunovsky M, Krajca V, Horacek J (2011) The effect of phenylethylamine hallucinogens on quantitative electronecephalography and behavior in rats. Behav Pharmacol 22:e38
28. Gentry WB, Ghafoor AU, Wessinger WD, Laurenzana EM, Hendrickson HP, Owens SM (2004) (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration. Pharmacol Biochem Behav 79:751-760
29. Geyer MA (1998) Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31(Suppl 2):73-79
30. Geyer MA, Light RK, Rose GJ, Petersen LR, Horwitt DD, Adams LM, Hawkins RL (1979) A characteristic effect of hallucinogens on investigatory responding in rats. Psychopharmacol (Berl) 65:35-40
31. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacol (Berl) 156:117-154
32. Glennon RA, Titeler M, Lyon RA (1988) A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse. Pharmacol Biochem Behav 30:597-601
33. Gold LH, Geyer MA, Koob GF (1989) Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. NIDA Res Monogr 94:101-126
34. Hegadoren KM, Martin-Iverson MT, Baker GB (1995) Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine. Psychopharmacology (Berl) 118:295-304
35. Huang HH, Bai YM (2011) Persistent psychosis after ingestion of a single tablet of '2C-B'. Prog Neuropsychopharmacol Biol Psychiatry 35:293-294
36. Jahng JW, Houpt TA, Wessel TC, Chen K, Shih JC, Joh TH (1997) Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 25:30-36
37. Kalgutkar AS, Dalvie DK, Castagnoli N Jr, Taylor TJ (2001) Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors. Chem Res Toxicol 14:1139-1162
38. Kanamori T, Tsujikawa K, Ohmae Y, Iwata YT, Inoue H, Kishi T, Nakahama T, Inouye Y (2005) A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes. Forensic Sci Int 148:131-137
39. Koch M (1999) The neurobiology of startle. Prog Neurobiol 59:107-128
40. Koch M, Schnitzler HU (1997) The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89:35-49
41. Krebs-Thomson K, Geyer MA (1996) The role of 5-HT(1A) receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats. Behav Pharmacol 7:551-559
42. Krebs-Thomson K, Paulus MP, Geyer MA (1998) Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 18:339-351
43. Kubesova A, Palenicek T, Votava M, Fujakova M, Tyls F, Sustkova M, Krsiak M (2011) The influence of 5-HT 1A/2A antagonists on changes in ultrasonic vocalization in rats induced by administration of MDMA and 2C-B. Behav Pharmacol 22:e71
44. Lát J (1973) The analysis of habituation. Acta Neurobiol Exp (Wars) 33:771-789
45. Lingford-Hughes A, Nutt D (2003) Neurobiology of addiction and implications for treatment. Br J Psychiatry 182:97-100
46. Lisman J, Buzsaki G (2008) A neural coding scheme formed by the combined function of gamma and theta oscillations. Schizophr Bull 34:974-980
47. Lobos M, Borges Y, Gonzalez E, Cassels BK (1992) The action of the psychoactive drug 2C-B on isolated rat thoracic aorta. Gen Pharmacol 23:1139-1142
48. Maloney KJ, Cape EG, Gotman J, Jones BE (1997) High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat. Neuroscience 76:541-555
49. Marona-Lewicka D, Nichols DE (2007) Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacol Biochem Behav 87:453-461
50. Marona-Lewicka D, Thisted RA, Nichols DE (2005) Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacol (Berl) 180:427-435
51. Masse F, Hascoet M, Bourin M (2007a) Effect of GABAergic ligands on the anxiolytic-like activity of DOI (a 5-HT(2A/2C) agonist) in the four-plate test in mice. Eur Neuropsychopharmacol 17:483-491
52. Masse F, Nic Dhonnchadha BA, Hascoet M, Bourin M (2007b) Anxiolytic-like effect of 5-HT(2) ligands and benzodiazepines co-administration: comparison of two animal models of anxiety (the four-plate test and the elevated plus maze). Behav Brain Res 177:214-226
53. Moya PR, Berg KA, Gutierrez-Hernandez MA, Saez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP (2007) Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Pharmacol Exp Ther 321:1054-1061
54. Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoactive Drugs 18:305-313
55. Palenicek T, Votava M, Bubenikova V, Horacek J (2005) Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Physiol Behav 86:546-553
56. 2C receptor SB242084 on rat's locomotion in animal models of psychosis). Adiktologie 10:16-19
57. Palenicek T, Hlinak Z, Bubenikova-Valesova V, Votava M, Horacek J (2007) An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Neuro Endocrinol Lett 28:781-788
58. Palenicek T, Balikova M, Bubenikova-Valesova V, Horacek J (2008) Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose. Psychopharmacol (Berl) 196:51-62
59. Palenicek T, Hlinak Z, Bubenikova-Valesova V, Novak T, Horacek J (2010) Sex differences in the effects of N, N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Prog Neuropsychopharmacol Biol Psychiatry 34:588-596
60. Palenicek T, Balikova M, Rohanova M, Novak T, Horacek J, Fujakova M, Hoschl C (2011a) Behavioral, hyperthermic and pharmacokinetic profile of para-methoxymethamphetamine (PMMA) in rats. Pharmacol Biochem Behav 98:130-139
61. Palenicek T, Fujakova M, Brunovsky M, Balikova M, Horacek J, Gorman I, Tyls F, Tislerova B, Sos P, Bubenikova-Valesova V, Hoschl C, Krajca V (2011b) Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics. Neuropsychobiology 63:202-218
62. Palenicek T, Fujakova M, Tyls F, Brunovsky M, Kubesova A, Horacek J, Krajca V (2011c) Quantitative EEG in animal models of psychosis: the impact of behaviour. Eur Neuropsychopharmacol 21:S317
63. Palenicek, T, Fujakova, M, Tyls, F, Kubesova, A, Brunovsky, M, Horacek, J, and Krajca, V (2011d) The impact of behavior on cortical EEG in rats. Neuroimaging through the lifespan: Brain development and brain diseases from adolescence to senescence - Joint meeting of ISNIP/lSBET/ECNS September 7-10, 2011, University of Heidelberg, Germany, Abstrakt Book: 106
64. Paulus MP, Geyer MA (1992) The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity. Neuropsychopharmacology 7:15-31
65. Paxinos G, Watson C (2003) The rat brain in stereotaxic coordinates, 4th edn. Elsevier, Academic Press, New York
66. Pontieri FE, Tanda G, Di CG (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 92:12304-12308
67. Principe JC, Smith JR (1986) Design and implementation of linear phase FIR filters for biological signal processing. IEEE Trans Biomed Eng 33:550-559
68. Rechtschaffen A, Bergmann BM, Gilliland MA, Bauer K (1999) Effects of method, duration, and sleep stage on rebounds from sleep deprivation in the rat. Sleep 22:11-31
69. Roberts AJ, Koob GF (1997) The neurobiology of addiction: an overview. Alcohol Health Res World 21:101-106
70. Rohanova M, Balikova M (2009) Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry. Leg Med (Tokyo) 11(Suppl 1):S429-S430
71. Rohanova M, Palenicek T, Balikova M (2008) Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicol Lett 178:29-36
72. Segura M, Ortuno J, Farre M, McLure JA, Pujadas M, Pizarro N, Llebaria A, Joglar J, Roset PN, Segura J, de la Torre R (2001) 3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem Res Toxicol 14:1203-1208
73. Shaw JC, O'Connor KP, Ongley OC (1978) EEG coherence as a measure of cerebral functional organization. In: Brazier MB, Petche H (eds) Architectonics of the cerebral cortex. Raven, New York, pp 245-256
74. Shulgin AT, Carter MF (1975) Centrally active phenethylamines. Psychopharmacol Commun 1:93-98
75. Shulgin A, Shulgin A (1991) PIHKAL: a chemical love story. Transform Press, Berkley, CA
76. Smolinske SC, Rastogi R, Schenkel S (2005) Foxy methoxy: a new drug of abuse. J Med Toxicol 1:22-25
77. Spanos LJ, Yamamoto BK (1989) Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Pharmacol Biochem Behav 32:835-840
78. Sumnall H, Wooding O (2009) Mephedrone - an update on current knowledge. Centre for Public Health, Liverpool John Moores University
79. Swerdlow NR, Braff DL, Geyer MA (2000) Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 11:185-204
80. Swerdlow NR, Geyer MA, Braff DL (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacol (Berl) 156:194-215
81. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker J, Auerbach PP (2003) Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology 28:640-650
82. Sykes EA (1986) Mescaline-induced motor impairment in rats, assessed by two different methods. Life Sci 39:1051-1058
83. Syslova K, Rambousek L, Kuzma M, Najmanova V, Bubenikova-Valesova V, Slamberova R, Kacer P (2011) Monitoring of dopamine and its metabolites in brain microdialysates: method combining freeze-drying with liquid chromatography-tandem mass spectrometry. J Chromatogr A 1218:3382-3391
84. Thatcher RW, Krause PJ, Hrybyk M (1986) Cortico-cortical associations and EEG coherence: a two-compartmental model. Electroencephalogr Clin Neurophysiol 64:123-143
85. Thatcher RW, Walker RA, Giudice S (1987) Human cerebral hemispheres develop at different rates and ages. Science 236:1110-1113
86. Thatcher RW, Biver CJ, North DM (2003) Quantitative EEG and the Frye and Daubert standards of admissibility. Clin Electroencephalogr 34:39-53
87. Thorlacius K, Borna C, Personne M (2008) Bromo-dragon fly-life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case. Lakartidningen 105:1199-1200
88. Tyls F, Palenicek T, Fujakova M, Kubesova A, Brunovsky M, Krajca V, Horacek J (2011) The effect of tryptamine hallucinogens on quantitative EEG and behavior in rats. Behav Pharmacol 22:e39
89. Varty GB, Walters N, Cohen-Williams M, Carey GJ (2001) Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains. Eur J Pharmacol 424:27-36
90. Vollenweider FX, Vontobel P, Hell D, Leenders KL (1999) 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man - a PET study with [11C]raclopride. Neuropsychopharmacology 20:424-433
91. Vyazovskiy V, Achermann P, Borbely AA, Tobler I (2004) Interhemispheric coherence of the sleep electroencephalogram in mice with congenital callosal dysgenesis. Neuroscience 124:481-488
92. Vyazovskiy VV, Ruijgrok G, Deboer T, Tobler I (2006) Running wheel accessibility affects the regional electroencephalogram during sleep in mice. Cereb Cortex 16:328-336
93. Vyazovskiy VV, Tobler I, Winsky-Sommerer R (2007) Alteration of behavior in mice by muscimol is associated with regional electroencephalogram synchronization. Neuroscience 147:833-841
94. Wecker JR, Ison JR (1986) Effects of motor-activity on the elicitation and modification of the startle reflex in rats. Anim Learn Behav 14:287-292
95. Wishaw IQ, Haun F, Kolb B (1999) Analysis of behavior in laboratory rodents. In: Windhorst U, Johansson H (eds) Modern techniques in neuroscience. Springer, Berlin, Germany, pp 1243-1275
96. Youdim MB, Riederer PF (2004) A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease. Neurology 63:S32-S35
97. Young GA (1988) Relationship between amphetamine-induced effects on EEG power spectra and motor activity in rats. Pharmacol Biochem Behav 30:489-492